ym 09151-2 has been researched along with sonepiprazole in 1 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (sonepiprazole) | Trials (sonepiprazole) | Recent Studies (post-2010) (sonepiprazole) |
---|---|---|---|---|---|
249 | 6 | 13 | 20 | 1 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatanaka, K; Hidaka, K; Matsumoto, M; Noda-Saita, K; Ohmori, J; Okada, M; Yamaguchi, T | 1 |
1 other study(ies) available for ym 09151-2 and sonepiprazole
Article | Year |
---|---|
Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
Topics: Animals; Anisoles; Benzamides; Binding Sites; Cerebral Cortex; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Ketanserin; Ligands; Macaca fascicularis; Pindolol; Piperazines; Propylamines; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Serotonin; Sulfonamides; Tritium | 1999 |